Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.
Carrato A, Pazo-Cid R, Macarulla T, Gallego J, Jiménez-Fonseca P, Rivera F, Cano MT, Rodriguez-Garrote M, Pericay C, Alés I, Layos L, Graña B, Iranzo V, Gallego I, Garcia-Carbonero R, de Mena IR, Guillén-Ponce C, Aranda E. Carrato A, et al. Among authors: pericay c. NEJM Evid. 2024 Feb;3(2):EVIDoa2300144. doi: 10.1056/EVIDoa2300144. Epub 2024 Jan 23. NEJM Evid. 2024. PMID: 38320486 Clinical Trial.
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Kubicka S, Greil R, André T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, Müller T, Makrutzki M, Arnold D; ML18147 study investigators including AIO, GERCOR, FFCD, UNICANCER GI, TTD, BGDO, GEMCAD, and AGMT groups. Kubicka S, et al. Ann Oncol. 2013 Sep;24(9):2342-9. doi: 10.1093/annonc/mdt231. Epub 2013 Jul 12. Ann Oncol. 2013. PMID: 23852309 Free article. Clinical Trial.
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study).
Fernandez-Plana J, Pericay C, Quintero G, Alonso V, Salud A, Mendez M, Salgado M, Saigi E, Cirera L; ACROSS Study Group. Fernandez-Plana J, et al. Among authors: pericay c. BMC Cancer. 2014 Nov 22;14:865. doi: 10.1186/1471-2407-14-865. BMC Cancer. 2014. PMID: 25417182 Free PMC article. Clinical Trial.
Predictors of 1- and 2-year mortality in patients with rectal cancer.
Quintana JM, González N, Lázaro S, Baré M, Fernández-de-Larrea N, Redondo M, Briones E, Escobar A, Sarasqueta C, García-Gutierrez S, Antón-Ladislao A; REDISSEC-CARESS/CCR group. Quintana JM, et al. Colorectal Dis. 2018 Aug;20(8):676-687. doi: 10.1111/codi.14250. Epub 2018 May 30. Colorectal Dis. 2018. PMID: 29745479
Dissection of the inferior mesenteric vein versus of the inferior mesenteric artery for the genitourinary function after laparoscopic approach of rectal cancer surgery: a randomized controlled trial.
Pallisera-Lloveras A, Planelles-Soler P, Hannaoui N, Mora-López L, Muñoz-Rodriguez J, Serra-Pla S, Dominguez-Garcia A, Prats-López J, Navarro-Soto S, Serra-Aracil X; Tauli-Colorectal Cancer Study Group. Pallisera-Lloveras A, et al. BMC Urol. 2019 Aug 5;19(1):75. doi: 10.1186/s12894-019-0501-5. BMC Urol. 2019. PMID: 31382934 Free PMC article. Clinical Trial.
Predictors of readmission and reoperation in patients with colorectal cancer.
Quintana JM, Anton-Ladislao A, Lázaro S, Gonzalez N, Bare M, de Larrea NF, Redondo M, Briones E, Escobar A, Sarasqueta C, Garcia-Gutierrez S; REDISSEC CARESS-CCR (Results and Health Services Research in Colorectal Cancer)- group. Quintana JM, et al. Support Care Cancer. 2020 May;28(5):2339-2350. doi: 10.1007/s00520-019-05050-2. Epub 2019 Sep 4. Support Care Cancer. 2020. PMID: 31485982
Outcomes of open versus laparoscopic surgery in patients with colon cancer.
Quintana JM, Antón-Ladisla A, González N, Lázaro S, Baré M, Fernández de Larrea N, Redondo M, Briones E, Escobar A, Sarasqueta C, García-Gutierrez S; REDISSEC-CARESS/CCR group. Quintana JM, et al. Eur J Surg Oncol. 2018 Sep;44(9):1344-1353. doi: 10.1016/j.ejso.2018.05.030. Epub 2018 Jun 6. Eur J Surg Oncol. 2018. PMID: 29921557 Clinical Trial.
Biological and prognostic differences between symptomatic colorectal carcinomas and those detected by screening.
Téllez T, Abitei C, Padilla-Ruiz MDC, Rivas-Ruiz F, Fúnez R, Pereda T, Rodrigo I, Alcaide J, Baré ML, Morales Suárez-Varela MM, Zabalza I, Sánchez Del Charco M, Borrero Martín JJ, García Del Moral R, Escobar A, Quintana JM, Aguirre U, Redondo M; REDISSEC-CARESS/CCR group. Téllez T, et al. Eur J Surg Oncol. 2019 Oct;45(10):1876-1881. doi: 10.1016/j.ejso.2019.05.027. Epub 2019 Jun 5. Eur J Surg Oncol. 2019. PMID: 31189513
119 results